Anchiano Therapeutics Ltd (ANCN:NASDAQ) rocketted at $4.67, representing a gain of 39.8%. The stock got featured on our News Catalysts scanner on Thu 18 Feb 21 at 04:59 PM in the 'INVESTOR UPDATE' category. From Fri 19 Feb 21, the stock recorded 50.00% Up Days and 45.45% Green Days
The stock spiked on Wed 10 Feb 21 at $10.55 with a volume of 46M+.
About Anchiano Therapeutics Ltd (ANCN:NASDAQ)
Anchiano Therapeutics Ltd is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of novel therapies to treat cancer in areas of unmet need.
Top 10 Gainers:
- Second Sight Medical Products, Inc. (EYES:NASDAQ), 103.28%
- Express, Inc. (EXPR:NYSE), 63.82%
- Greenwich LifeSciences Inc (GLSI:NASDAQ), 61.74%
- GameStop Corp. (GME:NYSE), 41.21%
- Anchiano Therapeutics Ltd (ANCN:NASDAQ), 39.82%
- OpGen, Inc. (OPGN:NASDAQ), 36.73%
- Jaguar Health, Inc. (JAGX:NASDAQ), 35.63%
- Chico's FAS, Inc. (CHS:NYSE), 32.05%
- MBIA Inc. (MBI:NYSE), 30.21%
- Koss Corporation (KOSS:NASDAQ), 27.54%